Durusu Tanrıöver, M. Et Al. 2021. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet , vol.398 , 213-222.

Durusu Tanrıöver, M., Doğanay, H. L., Akova, M., Güner, H. R., Azap, A., Akhan, S., ... Köse, Ş.(2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet , vol.398, 213-222.

Durusu Tanrıöver, Mine Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey," Lancet , vol.398, 213-222, 2021

Durusu Tanrıöver, Mine D. Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey." Lancet , vol.398, pp.213-222, 2021

Durusu Tanrıöver, M. Et Al. (2021) . "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey." Lancet , vol.398, pp.213-222.

@article{article, author={Mine Durusu Tanrıöver Et Al. }, title={Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey}, journal={Lancet}, year=2021, pages={213-222} }